Innitius, a Spanish startup specialized in improving diagnostics for women’s health, has raised €1.8M in a financing round led by Clave Capital and Nara Capital. Several existing investors also participated in the round. Founded in 2017 and based in Bilbao, Innitius is committed to enhancing the health and well-being of pregnant women and newborns by mitigating the impact of pathologies such as preterm birth, induction of birth, and cervical cancer in society.
Innitius leverages advanced technology and data analytics to develop cutting-edge medical devices that enable healthcare professionals to detect, diagnose, and treat women’s health issues more effectively. The company’s flagship product, the InnDX system, is a non-invasive, accurate, and easy-to-use diagnostic tool that allows doctors to monitor the cervical health of pregnant women, detect any anomalies, and take proactive measures to prevent preterm birth.
With the latest round of funding, Innitius plans to expand its product portfolio, strengthen its R&D capabilities, and broaden its market reach to cater to the growing demand for women’s health solutions worldwide. The company is also looking to collaborate with leading healthcare institutions and research organizations to advance the field of women’s health and bring more innovations to market.
